Ulla Seibel-Ehlert

Mrs. Ulla Seibel-Ehlert

University of Regensburg
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Carina HöringCarina Höring
Carina Höring
USUlla Seibel-Ehlert
Ulla Seibel-Ehlert
KTKatharina Tropmann
Katharina Tropmann
LGLukas Grätz
Lukas Grätz
DMDenise Mönnich
Denise Mönnich
ASAndrea Strasser
Andrea Strasser
In drug discovery, assays with proximal readout are of great importance to study target-specific effects of potential drug candidates. In the field of G protein-coupled receptors (GPCRs), the determination of GPCR-G protein interactions and G protein activation by means of radiolabeled GTP analogs ([35S]GTPγS, [γ-32P]GTP) has widely been used for this purpose. Since we were repeatedly faced with insufficient quality of radiolabeled nucleotides, there was a requirement to implement a novel proximal functional assay for the routine characterization of putative histamine receptor ligands. We applied the split-NanoLuc to the four histamine receptor subtypes (H1R, H2R, H3R, H4R) and recently engineered minimal G (mini-G) proteins. Using this method, the functional response upon receptor activation was monitored in real-time and the four mini-G sensors were evaluated by investigating selected standard (inverse) agonists and antagonists. All potencies and efficacies of the studied ligands were in concordance with literature data. Further, we demonstrated a significant positive correlation of the signal amplitude and the mini-G protein expression level in the case of the H2R, but not for the H1R or the H3R. The pEC50 values of histamine obtained under different mini-G expression levels were consistent. Moreover, we obtained excellent dynamic ranges (Z’ factor) and the signal spans were improved for all receptor subtypes in comparison to the previously performed [35S]GTPγS binding assay.

1 March 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KSKatarzyna Szczepańska
Katarzyna Szczepańska
SPSteffen Pockes
Steffen Pockes
SPSabina Podlewska
Sabina Podlewska
CHCarina Höring
Carina Höring
KMKamil Mika
Kamil Mika
KKKatarzyna Kiec-Kononowicz
Katarzyna Kiec-Kononowicz

Verified
Journal Article
Open access
PDF file
USUlla Seibel-Ehlert
Ulla Seibel-Ehlert
NPNicole Plank
Nicole Plank
AIAsuka Inoue
Asuka Inoue
GBGuenther Bernhardt
Guenther Bernhardt
ASAndrea Strasser
Andrea Strasser
G protein activation represents an early key event in the complex GPCR signal transduction process and is usually studied by label-dependent methods targeting specific molecular events. However, the constrained environment of such “invasive” techniques could interfere with biological processes. Although histamine receptors (HRs) represent (evolving) drug targets, their signal transduction is not fully understood. To address this issue, we established a non-invasive dynamic mass redistribution (DMR) assay for the human H1–4Rs expressed in HEK cells, showing excellent signal-to-background ratios above 100 for histamine (HIS) and higher than 24 for inverse agonists with pEC50 values consistent with literature. Taking advantage of the integrative nature of the DMR assay, the involvement of endogenous Gαq/11, Gαs, Gα12/13 and Gβγ proteins was explored, pursuing a two-pronged approach, namely that of classical pharmacology (G protein modulators) and that of molecular biology (Gα knock-out HEK cells). We showed that signal transduction of hH1–4Rs occurred mainly, but not exclusively, via their canonical Gα proteins. For example, in addition to Gαi/o, the Gαq/11 protein was proven to contribute to the DMR response of hH3,4Rs. Moreover, the Gα12/13 was identified to be involved in the hH2R mediated signaling pathway. These results are considered as a basis for future investigations on the (patho)physiological role and the pharmacological potential of H1–4Rs.

1 November 2021 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
KTKatharina Tropmann
Katharina Tropmann
USUlla Seibel-Ehlert
Ulla Seibel-Ehlert
TLTimo Littmann
Timo Littmann
ASAndrea Strasser
Andrea Strasser